62.50
0.22%
0.142
Overview
News
Price History
Option Chain
Financials
Why CTVA Down?
Discussions
Forecast
Dividend History
Corteva Inc stock is traded at $62.50, with a volume of 1.96M.
It is up +0.22% in the last 24 hours and up +9.59% over the past month.
Corteva is an agricultural inputs pure play that was formed in 2019 when it was spun off from DowDuPont. The company is a leader in the development of new seed and crop protection products. Seeds generate the majority of profits with the remainder coming from crop protection products. Corteva operates globally, but around half of revenue comes from North America.
See More
Previous Close:
$62.36
Open:
$62.5
24h Volume:
1.96M
Relative Volume:
0.58
Market Cap:
$42.75B
Revenue:
$16.64B
Net Income/Loss:
$695.00M
P/E Ratio:
63.13
EPS:
0.99
Net Cash Flow:
$651.00M
1W Performance:
-4.24%
1M Performance:
+9.59%
6M Performance:
+23.08%
1Y Performance:
+15.59%
Corteva Inc Stock (CTVA) Company Profile
Name
Corteva Inc
Sector
Industry
Phone
(833) 267-8382
Address
9330 ZIONSVILLE ROAD, INDIANAPOLIS, DE
Compare CTVA with other stocks
Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
---|---|---|---|---|---|---|
CTVA
Corteva Inc
|
62.50 | 42.75B | 16.64B | 695.00M | 651.00M | 0.99 |
NTR
Nutrien Ltd
|
50.52 | 24.92B | 26.56B | 733.00M | 2.33B | 1.49 |
CF
Cf Industries Holdings Inc
|
84.60 | 15.38B | 5.98B | 1.16B | 1.82B | 6.32 |
MOS
Mosaic Company
|
26.88 | 8.41B | 11.46B | 371.20M | 301.40M | 1.13 |
ICL
Icl Group Ltd
|
5.935 | 7.61B | 6.93B | 404.00M | 652.00M | 0.31 |
Corteva Inc Stock (CTVA) Upgrades & Downgrades
Date | Action | Analyst | Rating Change |
---|---|---|---|
Oct-23-24 | Initiated | Citigroup | Buy |
Oct-16-24 | Upgrade | BofA Securities | Neutral → Buy |
Aug-07-24 | Downgrade | Argus | Buy → Hold |
Apr-12-24 | Downgrade | JP Morgan | Overweight → Neutral |
Mar-01-24 | Initiated | Wolfe Research | Outperform |
Feb-12-24 | Upgrade | Loop Capital | Hold → Buy |
Feb-02-24 | Upgrade | Exane BNP Paribas | Underperform → Neutral |
Nov-27-23 | Downgrade | Berenberg | Buy → Hold |
Nov-14-23 | Downgrade | Barclays | Overweight → Equal Weight |
Oct-20-23 | Upgrade | Oppenheimer | Perform → Outperform |
Sep-05-23 | Upgrade | UBS | Neutral → Buy |
Jul-25-23 | Downgrade | Redburn | Buy → Neutral |
Jun-28-23 | Initiated | Canaccord Genuity | Buy |
May-22-23 | Upgrade | Vertical Research | Hold → Buy |
Apr-06-23 | Initiated | Oppenheimer | Perform |
Jan-19-23 | Initiated | Wells Fargo | Overweight |
Jan-11-23 | Upgrade | BofA Securities | Underperform → Neutral |
Nov-16-22 | Downgrade | UBS | Buy → Neutral |
Nov-15-22 | Downgrade | Loop Capital | Buy → Hold |
Aug-08-22 | Upgrade | JP Morgan | Neutral → Overweight |
Aug-08-22 | Upgrade | ROTH Capital | Neutral → Buy |
Jul-14-22 | Initiated | Credit Suisse | Outperform |
Jun-01-22 | Initiated | Barclays | Overweight |
May-06-22 | Downgrade | JP Morgan | Overweight → Neutral |
Apr-14-22 | Upgrade | Loop Capital | Hold → Buy |
Apr-14-22 | Downgrade | Vertical Research | Buy → Hold |
Jan-31-22 | Upgrade | Redburn | Neutral → Buy |
Oct-18-21 | Downgrade | Loop Capital | Buy → Hold |
Oct-13-21 | Initiated | Mizuho | Buy |
Oct-08-21 | Initiated | ROTH Capital | Buy |
Sep-01-21 | Initiated | Berenberg | Buy |
Aug-09-21 | Upgrade | Monness Crespi & Hardt | Sell → Neutral |
May-10-21 | Downgrade | BofA Securities | Buy → Underperform |
Apr-19-21 | Upgrade | Loop Capital | Hold → Buy |
Feb-05-21 | Upgrade | JP Morgan | Neutral → Overweight |
Feb-05-21 | Reiterated | Monness Crespi & Hardt | Sell |
Dec-18-20 | Downgrade | Susquehanna | Positive → Neutral |
Dec-14-20 | Upgrade | Morgan Stanley | Equal-Weight → Overweight |
Nov-10-20 | Upgrade | Argus | Hold → Buy |
Oct-19-20 | Upgrade | BofA Securities | Neutral → Buy |
Oct-19-20 | Downgrade | Exane BNP Paribas | Outperform → Underperform |
Aug-11-20 | Upgrade | KeyBanc Capital Markets | Sector Weight → Overweight |
Aug-10-20 | Downgrade | BofA Securities | Buy → Neutral |
Jul-13-20 | Upgrade | BofA Securities | Underperform → Buy |
Jun-26-20 | Initiated | Cleveland Research | Neutral |
Jun-16-20 | Upgrade | Vertical Research | Hold → Buy |
Jun-08-20 | Downgrade | Monness Crespi & Hardt | Neutral → Sell |
May-11-20 | Downgrade | BofA/Merrill | Neutral → Underperform |
Apr-17-20 | Downgrade | BofA/Merrill | Buy → Neutral |
Apr-17-20 | Upgrade | Loop Capital | Sell → Hold |
Apr-01-20 | Upgrade | Exane BNP Paribas | Neutral → Outperform |
Mar-31-20 | Upgrade | Susquehanna | Neutral → Positive |
Mar-26-20 | Initiated | KeyBanc Capital Markets | Sector Weight |
Mar-19-20 | Upgrade | Edward Jones | Hold → Buy |
Mar-13-20 | Upgrade | BofA/Merrill | Neutral → Buy |
Mar-10-20 | Upgrade | Monness Crespi & Hardt | Sell → Neutral |
View All
Corteva Inc Stock (CTVA) Latest News
If You Invested $100 In This Stock 5 Years Ago, You Would Have This Much Today - Benzinga
Agricultural Microbials Market Dynamics, Case Studies, and - GlobeNewswire
Corteva Inc (CTVA) Q4 2024 Earnings Call Highlights: Record EBITDA Margins and Robust Sales Growth - Yahoo Finance
Corteva Reports Strong Q4 Driven by Crop Demand - TipRanks
Corteva, Inc. Earnings Call Highlights Robust Growth - TipRanks
Corteva shares fall 4% on weak FY25 earnings guidance despite in-line Q4 results - MSN
Corteva, Inc. (CTVA) Reports Q4 Earnings: What Key Metrics Have to Say - MSN
Corteva outlines 10% EBITDA growth and $1B share repurchases for 2025 - MSN
Mizuho raises Corteva stock price target to $71 from $67 - MSN
Mizuho raises Corteva stock price target to $71 from $67 By Investing.com - Investing.com Canada
Corteva Inc (CTVA) Reports Q4 2024 Revenue of $4.0 Billion, EPS Loss of $0.08, Missing Estimates - GuruFocus.com
Agricultural Biologicals Market Key Players Analysis- - openPR
Corteva, Inc.: Q4 Earnings Snapshot - Barchart
Corteva, Inc. (CTVA) Lags Q4 Earnings Estimates - MSN
Corteva reports smaller fourth-quarter loss, shares slip on 2025 profit forecast - MSN
Corteva’s shares fall on disappointing guidance for year (CTVA:NYSE) - Seeking Alpha
Corteva reports smaller fourth-quarter loss - MSN
Corteva Q4 Non-GAAP Operating Earnings, Net Sales Rise; Shares Fall After Hours - Marketscreener.com
Corteva, Inc.: Q4 Earnings Snapshot | National Business News | voiceofalexandria.com - Voice Of Alexandria
Corteva earnings matched, revenue fell short of estimates By Investing.com - Investing.com Canada
Earnings Flash (CTVA) CORTEVA Reports Q4 Adjusted EPS $0.32, vs. FactSet Est of $0.31 - Marketscreener.com
Earnings Breakdown: Corteva Q4 - Benzinga
Corteva reports smaller fourth-quarter loss -February 05, 2025 at 04:35 pm EST - Marketscreener.com
Corteva Strong 4Q Driven by Record Crop Demand, Disciplined Execution - PR Newswire
Is Corteva, Inc. (CTVA) the Best Wide Moat Stock to Invest In? - Insider Monkey
Is Corteva, Inc. (CTVA) the Best Wide Moat Stocks to Invest In? - Yahoo Finance
Gear Up for Corteva, Inc. (CTVA) Q4 Earnings: Wall Street Estimates for Key Metrics - MSN
Agricultural Pesticides Market Is Booming So Rapidly | Corteva, ADAMA, Albaugh - openPR
CENTRAL TRUST Co Sells 5,063 Shares of Corteva, Inc. (NYSE:CTVA) - MarketBeat
DAVENPORT & Co LLC Cuts Stock Position in Corteva, Inc. (NYSE:CTVA) - MarketBeat
Caprock Group LLC Purchases 8,238 Shares of Corteva, Inc. (NYSE:CTVA) - MarketBeat
Corteva, Inc. (NYSE:CTVA) Shares Sold by SG Americas Securities LLC - MarketBeat
Corteva, Inc. (NYSE:CTVA) Shares Bought by Pacer Advisors Inc. - MarketBeat
Swedbank AB Boosts Stake in Corteva, Inc. (NYSE:CTVA) - MarketBeat
Citigroup Forecasts Strong Price Appreciation for Corteva (NYSE:CTVA) Stock - MarketBeat
Robeco Institutional Asset Management B.V. Reduces Position in Corteva, Inc. (NYSE:CTVA) - MarketBeat
Janney Montgomery Scott LLC Purchases 12,800 Shares of Corteva, Inc. (NYSE:CTVA) - MarketBeat
Corteva (NYSE:CTVA) Reaches New 52-Week High Following Analyst Upgrade - MarketBeat
SG Americas Securities LLC Reduces Holdings in Corteva, Inc. (NYSE:CTVA) - Defense World
Corteva (CTVA) Expected to Announce Earnings on Wednesday - MarketBeat
Corteva (NYSE:CTVA) Given New $73.00 Price Target at Wells Fargo & Company - MarketBeat
Agricultural Microbial Market Report and Competitive - GlobeNewswire
Agricultural Microbial Market Report and Competitive Landscape 2025, Featuring Bayer CropScience, AgBiome, BioAg Alliance, Corteva Agriscience, BioConsortia, Phyllom BioProducts & Valent BioSciences - Yahoo Finance
Mancozeb Market reached US$ 1.81 billion in 2022 and is expected - openPR
Farmers' Antitrust Claims Trimmed In Pesticides Case - Law360
Corteva, Inc. (CTVA) Reports Next Week: Wall Street Expects Earnings Growth - MSN
Syngenta, Corteva must face part of U.S. farmers’ antitrust lawsuit over pesticide prices - Canadian Cattlemen
Corteva Inc Stock (CTVA) Financials Data
Revenue
Net Income
Cash Flow
EPS
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):